Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
Open Access
- 1 January 2014
- journal article
- research article
- Published by Elsevier in Molecular Therapy
- Vol. 22 (1) , 233-238
- https://doi.org/10.1038/mt.2013.162
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- A T Cell-Inducing Influenza Vaccine for the Elderly: Safety and Immunogenicity of MVA-NP+M1 in Adults Aged over 50 YearsPLOS ONE, 2012
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in HumansClinical Infectious Diseases, 2012
- Antibody Repertoire: Embracing DiversityScience Translational Medicine, 2011
- Antibody and Th1-type cell-mediated immune responses in elderly and young adults immunized with the standard or a high dose influenza vaccinePublished by Elsevier ,2011
- Multiple Innate Immune Pathways Contribute to the Immunogenicity of Recombinant Adenovirus Vaccine VectorsJournal of Virology, 2011
- Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1Clinical Infectious Diseases, 2011
- Randomized, Double‐Blind Controlled Phase 3 Trial Comparing the Immunogenicity of High‐Dose and Standard‐Dose Influenza Vaccine in Adults 65 Years of Age and OlderThe Journal of Infectious Diseases, 2009
- Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 InflammasomePLoS Pathogens, 2009
- Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccinesVaccine, 2008
- Cytotoxic T-Cell Immunity to InfluenzaNew England Journal of Medicine, 1983